Clinical trial
An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
NCT04555161 is registered in ClinicalTrials.gov with Aria CV, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
- Lead sponsor
- Aria CV, Inc
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 15, 2021
- Completion date
- October 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary arterial hypertension, pulmonary hypertension, right heart dysfunction